ARS Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SPRY and other ETFs, options, and stocks.About SPRY
ARS Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development of a novel, potentially first-in-class product candidate, neffy, for the emergency treatment of Type I allergic reactions including anaphylaxis. Its product includes Epinephrine Nasal Spray.
CEORichard E. Lowenthal
CEORichard E. Lowenthal
Employees160
Employees160
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2015
Founded2015
Employees160
Employees160
SPRY Key Statistics
Market cap986.51M
Market cap986.51M
Price-Earnings ratio-11.79
Price-Earnings ratio-11.79
Dividend yield—
Dividend yield—
Average volume2.32M
Average volume2.32M
High today$10.02
High today$10.02
Low today$9.44
Low today$9.44
Open price$9.50
Open price$9.50
Volume1.43M
Volume1.43M
52 Week high$18.90
52 Week high$18.90
52 Week low$6.66
52 Week low$6.66
Stock Snapshot
The current ARS Pharmaceuticals(SPRY) stock price is $9.97, with a market capitalization of 986.51M. The stock trades at a price-to-earnings (P/E) ratio of -11.79.
During the trading session on 2025-12-04, ARS Pharmaceuticals(SPRY) shares reached a daily high of $10.02 and a low of $9.44. At a current price of $9.97, the stock is +5.6% higher than the low and still -0.5% under the high.
Trading activity shows a volume of 1.43M, compared to an average daily volume of 2.32M.
The stock's 52-week range extends from a low of $6.66 to a high of $18.90.
The stock's 52-week range extends from a low of $6.66 to a high of $18.90.
Analyst ratings
100%
of 6 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own SPRY. This list is generated using Robinhood data, and it’s not a recommendation.